Peripubertal Diazepam Administration Prevents the Emergence of Dopamine System Hyperresponsivity in the MAM Developmental Disruption Model of Schizophrenia

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892 · see citing works

Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies

Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356 · see citing works

Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States

Yung, A. R., Yung, A. R., Yuen, H. P., McGorry, P. D., Phillips, L., Kelly, D., Dell’Olio, M., Francey, S. M., Cosgrave, E., Killackey, E. J., et al. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01714.x · Cited by 2,195 · see citing works

Prodromal Assessment With the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: Predictive Validity, Interrater Reliability, and Training to Reliability

Miller, T. J., McGlashan, T. H., Rosen, J. L., Cadenhead, K. S., Ventura, J., McFarlane, W. R., Perkins, D. O., Pearlson, G. D., & Woods, S. W. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007040 · Cited by 1,800 · see citing works

Cortisol levels during human aging predict hippocampal atrophy and memory deficits

Lupien, S. J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N. P. V., Thakur, M., McEwen, B. S., Hauger, R. L., & Meaney, M. J. (1998) · Nature Neuroscience · doi:10.1038/271 · Cited by 1,653 · see citing works

Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia

Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.10.004 · Cited by 1,071 · see citing works

Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization

Grace, A. A., & Bunney, B. S. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90135-5 · Cited by 937 · see citing works

Schizophrenia: A neural diathesis-stress model.

Walker, E. F., & Diforio, D. (1997) · Psychological Review · doi:10.1037//0033-295x.104.4.667 · Cited by 930 · see citing works

Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocorticoid secretion and excitatory amino acid receptors

Magarin˜os, A. M., & McEwen, B. S. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00259-l · Cited by 863 · see citing works

Hippocampal Volume Reduction in Schizophrenia as Assessed by Magnetic Resonance Imaging

Nelson, M. D., Saykin, A. J., Flashman, L. A., & Riordan, H. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.5.433 · Cited by 756 · see citing works

Increased dopamine transmission in schizophrenia: relationship to illness phases.

Laruelle, M., Abi-Dargham, A., Gil, R. B., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 744 · see citing works

Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy

Conrad, C. D., Magariños, A. M., LeDoux, J. E., & McEwen, B. S. (1999) · Behavioral Neuroscience · doi:10.1037/0735-7044.113.5.902 · Cited by 664 · see citing works

Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy.

Conrad, C. D., Magariños, A. M., LeDoux, J. E., & McEwen, B. S. (1999) · Behavioral Neuroscience · doi:10.1037//0735-7044.113.5.902 · Cited by 663 · see citing works

Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia

Walker, E., Mittal, V., & Tessner, K. (2008) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.4.022007.141248 · Cited by 615 · see citing works

Hypothalamic Abnormalities in Schizophrenia: Sex Effects and Genetic Vulnerability

Goldstein, J. M., Seidman, L. J., Makris, N., Ahern, T., O’Brien, L. M., Caviness, V. S., Kennedy, D. N., Faraone, S. V., & Tsuang, M. T. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.027 · Cited by 542 · see citing works

A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia

Lodge, D. J., Behrens, M. M., & Grace, A. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5419-08.2009 · Cited by 488 · see citing works

Aberrant Hippocampal Activity Underlies the Dopamine Dysregulation in an Animal Model of Schizophrenia

Lodge, D., & Grace, A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2847-07.2007 · Cited by 475 · see citing works

A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia

Zhang, Z. J., & Reynolds, G. P. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00188-8 · Cited by 460 · see citing works

The stress cascade and schizophrenia: Etiology and onset

Corcoran, C., Walker, E., Huot, R., Mittal, V., Tessner, K., Kestler, L., & Malaspina, D. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007038 · Cited by 439 · see citing works

Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons

Ungless, M. A., & Grace, A. A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.02.003 · Cited by 431 · see citing works

Neural development, cell-cell signaling, and the “two-hit” hypothesis of schizophrenia

Maynard, T. M., Sikich, L., Lieberman, J. A., & LaMantia, A.-S. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006887 · Cited by 383 · see citing works

Differential Targeting of the CA1 Subfield of the Hippocampal Formation by Schizophrenia and Related Psychotic Disorders

Schobel, S., Lewandowski, N. M., Corcoran, C. M., Moore, H. M., Brown, T. R., Malaspina, D., & Small, S. A. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.115 · Cited by 364 · see citing works

A Neurobehavioral Systems Analysis of Adult Rats Exposed to Methylazoxymethanol Acetate on E17: Implications for the Neuropathology of Schizophrenia

Moore, H. M., Jentsch, J. D., Ghajarnia, M., Geyer, M. A., & Grace, A. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.003 · Cited by 359 · see citing works

Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ ¹⁸ F]-DOPA PET Imaging Study

Howes, O. D., Bose, S. K., Turkheimer, F., Valli, I., Egerton, A., Valmaggia, L. R., Murray, R. M., & McGuire, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010160 · Cited by 343 · see citing works

Dopamine Attenuates Prefrontal Cortical Suppression of Sensory Inputs to the Basolateral Amygdala of Rats

Rosenkranz, J. A., & Grace, A. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-11-04090.2001 · Cited by 339 · see citing works

Stress and Inflammation Reduce Brain-Derived Neurotrophic Factor Expression in First-Episode Psychosis

Mondelli, V., Cattaneo, A., Murri, M. B., Forti, M. D., Handley, R., Hepgul, N., Miorelli, A., Navari, S., Papadopoulos, A. S., Aitchison, K. J., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06745 · Cited by 305 · see citing works

Probing the human hippocampus using rCBF: Contrasts in schizophrenia

Medoff, D. R., Holcomb, H. H., Lahti, A. C., & Tamminga, C. A. (2001) · Hippocampus · doi:10.1002/hipo.1070 · Cited by 257 · see citing works

Can Antidepressants Be Used to Treat the Schizophrenia Prodrome?

Cornblatt, B. A., Lencz, T., Smith, C. W., Olsen, R. H., Auther, A. M., Nakayama, E. Y., LESSER, M. L., Tai, J. Y., Shah, M., Foley, C. A., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0410 · Cited by 218 · see citing works

Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia

Lodge, D. J., & Grace, A. A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.01.031 · Cited by 215 · see citing works

Disruption of Neurogenesis on Gestational Day 17 in the Rat Causes Behavioral Changes Relevant to Positive and Negative Schizophrenia Symptoms and Alters Amphetamine-Induced Dopamine Release in Nucleus Accumbens

Flagstad, P., Mørk, A., Glenthøj, B., van Beek, J., Michael-Titus, A., & Didriksen, M. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300516 · Cited by 210 · see citing works

Evidence for altered trisynaptic circuitry in schizophrenic hippocampus

Benes, F. M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00136-5 · Cited by 170 · see citing works

A Novel α5GABAAR-Positive Allosteric Modulator Reverses Hyperactivation of the Dopamine System in the MAM Model of Schizophrenia

Gill, K., Lodge, D., Cook, J., Aras, S., & Grace, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.76 · Cited by 170 · see citing works

Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms.

Thompson, J. L., Pogue-Geile, M., & Grace, A. (2004) · Schizophrenia bulletin · doi:10.1093/oxfordjournals.schbul.a007139 · Cited by 148 · see citing works

Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis

Mondelli, V., Pariante, C. M., Navari, S., Aas, M., D'Albenzio, A., Di Forti, M., Handley, R., Hepgul, N., Marques, T. R., Taylor, H., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.021 · Cited by 144 · see citing works

Risperidone Administered During Asymptomatic Period of Adolescence Prevents the Emergence of Brain Structural Pathology and Behavioral Abnormalities in an Animal Model of Schizophrenia

Piontkewitz, Y., Arad, M., & Weiner, I. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq040 · Cited by 143 · see citing works

Altered Relationship Between Hippocampal Glutamate Levels and Striatal Dopamine Function in Subjects at Ultra High Risk of Psychosis

Stone, J. M., Howes, O. D., Egerton, A., Kambeitz, J. P., Allen, P., Lythgoe, D. J., Tuura, R., McLean, M. A., Barker, G. J., & McGuire, P. K. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.034 · Cited by 133 · see citing works

Pathogenesis of schizophrenia: a psychopathological perspective

Owens, D. G. C., Miller, P., Lawrie, S., & Johnstone, E. C. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.186.5.386 · Cited by 130 · see citing works

Longitudinal changes in cortisol secretion and conversion to psychosis in at-risk youth.

Walker, E. F., Brennan, P. A., Esterberg, M., Brasfield, J., Pearce, B., & Compton, M. T. (2010) · Journal of Abnormal Psychology · doi:10.1037/a0018399 · Cited by 127 · see citing works

Decrease in parvalbumin‐expressing neurons in the hippocampus and increased phencyclidine‐induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia

Penschuck, S., Flagstad, P., Didriksen, M., Leist, M., & Michael-Titus, A. T. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04536.x · Cited by 127 · see citing works

Stress and psychosis: Towards the development of new models of investigation

Phillips, L., Francey, S. M., Edwards, J., & McMurray, N. E. (2006) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.10.003 · Cited by 113 · see citing works

Temporal association of stress sensitivity and symptoms in individuals at clinical high risk for psychosis

DeVylder, J., Ben‐David, S., Schobel, S., Kimhy, D., Malaspina, D., & Corcoran, C. M. (2012) · Psychological Medicine · doi:10.1017/s0033291712001262 · Cited by 105 · see citing works

Alterations in Medial Prefrontal Cortical Activity and Plasticity in Rats with Disruption of Cortical Development

Goto, Y., & Grace, A. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.046 · Cited by 100 · see citing works

Prospective relationship of duration of untreated psychosis to psychopathology and functional outcome over 12 years

Hill, M. B., Crumlish, N., Clarke, M., Whitty, P., Owens, E., Renwick, L., Browne, S., Macklin, E. A., Kinsella, A., Larkin, C., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.08.013 · Cited by 100 · see citing works

Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats

Piontkewitz, Y., Bernstein, H., Dobrowolny, H., Bogerts, B., Weiner, I., & Keilhoff, G. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.11.004 · Cited by 93 · see citing works

HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia

Corcoran, C. M., Smith, C., McLaughlin, D., Auther, A., Malaspina, D., & Cornblatt, B. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.035 · Cited by 85 · see citing works

Schizophrenia Genes - Famine to Feast

Straub, R. E., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.002 · Cited by 79 · see citing works

Ultrastructural features of the nitric oxide synthase-containing interneurons in the nucleus accumbens and their relationship with tyrosine hydroxylase-containing terminals

Hidaka, S., & Totterdell, S. (2001) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20010305)431:2 · Cited by 72 · see citing works

SPECT study of visual fixation in schizophrenia and comparison subjects

Malaspina, D., Storer, S., Furman, V., Esser, P. D., PRINTZ, D. J., Berman, A., Lignelli, A., Gorman, J. M., & Heertum, R. V. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00306-0 · Cited by 68 · see citing works

First-Episode Psychosis: An Inflammatory State?

Zajkowska, Z., & Mondelli, V. (2014) · NeuroImmunoModulation · doi:10.1159/000356536 · Cited by 67 · see citing works

The Modulation of Corticoaccumbens Transmission by Limbic Afferents and Dopamine: A Model for the Pathophysiology of Schizophrenia

Grace, A. A., Moore, H. M., & O’Donnell, P. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60849-2 · Cited by 56 · see citing works

Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia.

Phillips, L., Yung, A., Yuen, H. P., Pantelis, C., & McGorry, P. (2002) · American journal of medical genetics · doi:10.1002/ajmg.b.10790 · Cited by 56 · see citing works

Stress and the Prodromal Phase of Psychosis

Holtzman, C. W., Shapiro, D. I., Trotman, H. D., & Walker, E. F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799316280 · Cited by 49 · see citing works

Pituitary volume, stress reactivity and genetic risk for psychotic disorder

Habets, P., Collip, D., Myin-Germeys, I., Gronenschild, E., van Bronswijk, S., Hofman, P., Lataster, T., Lardinois, M., Nicolson, N. A., van Os, J., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711002728 · Cited by 46 · see citing works

Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia

Molina, V., Reig, S., Pascau, J., Sanz, J., Sarramea, F., Gispert, J. D., Luque, R., Carlos Benito, C., Palomo, T., & Desco, M. (2003) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(03)00107-0 · Cited by 44 · see citing works

Use of food wafers for multiple daily oral treatments in young rats.

Ferguson, S. A., & Boctor, S. Y. (2009) · PubMed Central · Cited by 25 · see citing works

Pituitary Volume Predicts Future Transition to Psychosis in Individuals at Ultra-High Risk of Developing Psychosis

Garner, B., Pariante, C. M., Wood, S. J., Velakoulis, D., Phillips, L., Soulsby, B., Brewer, W. J., Smith, D. J., Dazzan, P., Berger, G. E., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.018 · Cited by 8 · see citing works

Model of SChizoPhrenia

Brada, M. (1998) · PhilPapers (PhilPapers Foundation) · Cited by 4 · see citing works

Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression

Grace, A. A. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.57 · Cited by 1,166 · see citing works

Schizophrenia: an integrated sociodevelopmental-cognitive model

Howes, O. D., & Murray, R. M. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62036-x · Cited by 864 · see citing works

Altering the course of schizophrenia: progress and perspectives

Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.28 · Cited by 516 · see citing works

Developmental timing and critical windows for the treatment of psychiatric disorders

Marín, O. (2016) · Nature Medicine · doi:10.1038/nm.4225 · Cited by 374 · see citing works

Oscillations and Neuronal Dynamics in Schizophrenia: The Search for Basic Symptoms and Translational Opportunities

Uhlhaas, P. J., & Singer, W. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.11.019 · Cited by 243 · see citing works

Translating the MAM model of psychosis to humans

Modinos, G., Allen, P., Grace, A. A., & McGuire, P. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2014.12.005 · Cited by 165 · see citing works

Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia

Do, K. Q., Cuenod, M., & Hensch, T. K. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv065 · Cited by 158 · see citing works

The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention

Grace, A. A., & Gomes, F. V. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx199 · Cited by 152 · see citing works

Adolescent Neurodevelopment and Vulnerability to Psychosis

Patel, P. K., Leathem, L. D., Currin, D. L., & Karlsgodt, K. H. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.028 · Cited by 152 · see citing works

Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia

Sonnenschein, S. F., Gomes, F. V., & Grace, A. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00613 · Cited by 132 · see citing works

Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model

Gomes, F. V., Rincón‐Cortés, M., & Grace, A. A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.030 · Cited by 128 · see citing works

Stress during critical periods of development and risk for schizophrenia

Gomes, F. V., Zhu, X., & Grace, A. A. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.01.030 · Cited by 126 · see citing works

Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development

Egerton, A., Grace, A. A., Stone, J. M., Bossong, M. G., Sand, M. S., & McGuire, P. K. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.013 · Cited by 113 · see citing works

Advantages and Limitations of Animal Schizophrenia Models

Białoń, M., & Wąsik, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115968 · Cited by 97 · see citing works

Maternal Immune Activation Disrupts Dopamine System in the Offspring

Luchicchi, A., Lecca, S., Melis, M., Felice, M. D., Cadeddu, F., Frau, R., Muntoni, A. L., Fadda, P., Devoto, P., & Pistis, M. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw007 · Cited by 96 · see citing works

Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia

Štark, T., Kučerová, J., Iannotti, F. A., D’Addario, C., Marco, R. D., Pekařík, V., Dražanová, E., Piscitelli, F., Bari, M., Babinská, Z., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.035 · Cited by 89 · see citing works

Prefrontal Cortex Dysfunction Increases Susceptibility to Schizophrenia-Like Changes Induced by Adolescent Stress Exposure

Gomes, F. V., & Grace, A. A. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw156 · Cited by 76 · see citing works

Adolescent Stress as a Driving Factor for Schizophrenia Development—A Basic Science Perspective

Gomes, F. V., & Grace, A. A. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx033 · Cited by 77 · see citing works

Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models

Wegrzyn, D., Juckel, G., & Faissner, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105482 · Cited by 73 · see citing works

Effects of Pubertal Cannabinoid Administration on Attentional Set-Shifting and Dopaminergic Hyper-Responsivity in a Developmental Disruption Model of Schizophrenia

Gomes, F. V., Guimarães, F. S., & Grace, A. A. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu018 · Cited by 68 · see citing works

The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis

Taylor, S. F., Grove, T. B., Ellingrod, V. L., & Tso, I. F. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz046 · Cited by 67 · see citing works

Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention

Gomes, F. V., & Grace, A. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094467 · Cited by 63 · see citing works

Hippocampal circuit dysfunction in psychosis

Knight, S., McCutcheon, R. A., Dwir, D., Grace, A. A., O’Daly, O., McGuire, P. K., & Modinos, G. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02115-5 · Cited by 58 · see citing works

The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia

Uliana, D. L., Lisboa, J. R., Gomes, F. V., & Grace, A. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116298 · Cited by 65 · see citing works

Abnormal Stress Responsivity in a Rodent Developmental Disruption Model of Schizophrenia

Zimmerman, E. C., Bellaire, M., Ewing, S. G., & Grace, A. A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.110 · Cited by 63 · see citing works

Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia model

Gill, K. M., & Grace, A. A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571400056x · Cited by 60 · see citing works

Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration

Du, Y., & Grace, A. A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.42 · Cited by 59 · see citing works

Prospective Analysis of the Effects of Maternal Immune Activation on Rat Cytokines during Pregnancy and Behavior of the Male Offspring Relevant to Schizophrenia

Lins, B. R., Hurtubise, J. L., Roebuck, A. J., Marks, W. N., Zabder, N. K., Scott, G. A., Greba, Q., Dawicki, W., Zhang, X., Rudulier, C. D., et al. (2018) · eNeuro · doi:10.1523/eneuro.0249-18.2018 · Cited by 59 · see citing works

Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis

Modinos, G., Şimşek, F., Azis, M., Bossong, M. G., Bonoldi, I., Samson, C., Quinn, B., Pérez, J., Broome, M. R., Zelaya, F. O., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-017-0004-6 · Cited by 52 · see citing works

Schizophrenia — an anxiety disorder?

Hall, J. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.195370 · Cited by 52 · see citing works

Maternal Immune Activation during Pregnancy Alters the Behavior Profile of Female Offspring of Sprague Dawley Rats

Lins, B. R., Marks, W. N., Zabder, N. K., Greba, Q., & Howland, J. G. (2019) · eNeuro · doi:10.1523/eneuro.0437-18.2019 · Cited by 50 · see citing works

Prepubertal Environmental Enrichment Prevents Dopamine Dysregulation and Hippocampal Hyperactivity in MAM Schizophrenia Model Rats

Zhu, X., & Grace, A. A. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.09.023 · Cited by 47 · see citing works

Female rats are resistant to the long-lasting neurobehavioral changes induced by adolescent stress exposure

Klinger, K., Gomes, F. V., Rincón‐Cortés, M., & Grace, A. A. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.07.134 · Cited by 46 · see citing works

Loss of Parvalbumin in the Hippocampus of MAM Schizophrenia Model Rats Is Attenuated by Peripubertal Diazepam

Du, Y., & Grace, A. A. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw065 · Cited by 43 · see citing works

Dopamine System Dysregulation and the Pathophysiology of Schizophrenia: Insights From the Methylazoxymethanol Acetate Model

Grace, A. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.007 · Cited by 40 · see citing works

Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies

Potasiewicz, A., Hołuj, M., Litwa, E., Gzieło, K., Socha, L., Popik, P., & Nikiforuk, A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108040 · Cited by 39 · see citing works

Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice

Takahashi, K., Nakagawasai, O., Sakuma, W., Nemoto, W., Odaira, T., Lin, J.-R., Onogi, H., Srivastava, L. K., & Tan–No, K. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.02.034 · Cited by 37 · see citing works

Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats

Kučerová, J., Babinská, Z., Amchová, P., Štark, T., Drago, F., Šulcová, A., & Micale, V. (2016) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1190032 · Cited by 38 · see citing works

Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis

Modinos, G., Kempton, M., Tognin, S., Calem, M., Porffy, L., Antoniades, M., Mason, A. J. C., Azis, M., Allen, P., Nelson, B., et al. (2019) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2019.3501 · Cited by 42 · see citing works

Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia

Sonnenschein, S. F., & Grace, A. A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.009 · Cited by 36 · see citing works

Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study

Modinos, G., McLaughlin, A. P., Egerton, A., McMullen, K., Kumari, V., Barker, G. J., Keysers, C., & Williams, S. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.53 · Cited by 35 · see citing works

Cortical GABA in Subjects at Ultra-High Risk of Psychosis: Relationship to Negative Prodromal Symptoms

Modinos, G., Şimşek, F., Horder, J., Bossong, M. G., Bonoldi, I., Azis, M., Pérez, J., Broome, M. R., Lythgoe, D. J., Stone, J. M., et al. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx076 · Cited by 33 · see citing works

Impaired contextual fear-conditioning in MAM rodent model of schizophrenia

Gill, K., Miller, S. A., & Grace, A. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.08.064 · Cited by 28 · see citing works

Using animal models for the studies of schizophrenia and depression: The value of translational models for treatment and prevention

Uliana, D. L., Zhu, X., Gomes, F. V., & Grace, A. A. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.935320 · Cited by 32 · see citing works

A Network Analysis of Epigenetic and Transcriptional Regulation in a Neurodevelopmental Rat Model of Schizophrenia With Implications for Translational Research

Du, Y., Li, X., Chen, L., Chen, G.-Y., & Cheng, Y. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz114 · Cited by 31 · see citing works

Protracted maturation of forebrain afferent connections of the ventral tegmental area in the rat

Yetnikoff, L., Reichard, R. A., Schwartz, Z. M., Parsely, K. P., & Zahm, D. S. (2014) · Journal of Comparative Neurology · doi:10.1002/cne.23459 · Cited by 30 · see citing works

Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model

Kaneko, G., Sanganahalli, B. G., Groman, S. M., Wang, H., Coman, D., Rao, J. U., Hermán, P., Jiang, L., Rich, K. M., de Graaf, R. A., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.019 · Cited by 30 · see citing works

State-dependent effects of the D2 partial agonist aripiprazole on dopamine neuron activity in the MAM neurodevelopmental model of schizophrenia

Sonnenschein, S. F., Gill, K. M., & Grace, A. A. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0219-1 · Cited by 31 · see citing works

Stress Exposure in Dopamine D4 Receptor Knockout Mice Induces Schizophrenia-Like Behaviors via Disruption of GABAergic Transmission

Tan, T., Wang, W., Williams, J., Ma, K., Cao, Q., & Yan, Z. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby163 · Cited by 29 · see citing works

Alterations in spatial memory and anxiety in the MAM E17 rat model of hippocampal pathology in schizophrenia

Gastambide, F., Taylor, A. M., Palmer, C. E., Svärd, H., Karjalainen, M., Janhunen, S. K., Tricklebank, M. D., & Bannerman, D. M. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3862-1 · Cited by 29 · see citing works

Are CB2 Receptors a New Target for Schizophrenia Treatment?

Cortez, I. L., da Silva, N. R., Guimarães, F. S., & Gomes, F. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.587154 · Cited by 29 · see citing works

Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of rats

Potasiewicz, A., Hołuj, M., Piotrowska, D., Zajda, K., Wojcik, M., Popik, P., & Nikiforuk, A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.023 · Cited by 28 · see citing works

An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia

Chen, L., Perez, S. M., & Lodge, D. J. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22172 · Cited by 24 · see citing works

Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis

Sonnenschein, S. F., & Grace, A. A. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1849144 · Cited by 23 · see citing works

Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β

Xing, B., Han, G., Wang, M.-J., Snyder, M. A., & Gao, W. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.019 · Cited by 23 · see citing works

Hyperactive behavior in female rats <i>in utero</i>‐exposed to group B <i>Streptococcus</i>‐induced inflammation

Allard, M., Brochu, M., Bergeron, J. D., & Sebire, G. (2018) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2018.06.005 · Cited by 22 · see citing works

Adolescent Social Isolation Affects Schizophrenia-Like Behavior in the MAM-E17 Model of Schizophrenia

Bator, E., Latusz, J., Głowacka, U., Radaszkiewicz, A., Mudlaff, K., & Maćkowiak, M. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9888-0 · Cited by 22 · see citing works

The MAM-E17 schizophrenia rat model: Comprehensive behavioral analysis of pre-pubertal, pubertal and adult rats

Kállai, V., Tóth, A., Gálosi, R., Péczely, L., Ollmann, T., Petykó, Z., László, K., Kállai, J., Szabó, I., Karádi, Z., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.05.065 · Cited by 21 · see citing works

The mGluR2/3 agonist pomaglumetad methionil normalizes aberrant dopamine neuron activity via action in the ventral hippocampus

Sonnenschein, S. F., & Grace, A. A. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0764-2 · Cited by 19 · see citing works

GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia

Kiemes, A., Gomes, F. V., Cash, D., Uliana, D. L., Simmons, C., Singh, N., Vernon, A. C., Turkheimer, F., Davies, C., Stone, J. M., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01213-0 · Cited by 19 · see citing works

Peripubertal mGluR2/3 Agonist Treatment Prevents Hippocampal Dysfunction and Dopamine System Hyperactivity in Adulthood in MAM Model of Schizophrenia

Sonnenschein, S. F., & Grace, A. A. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab047 · Cited by 16 · see citing works

Update on current animal models for schizophrenia: are they still useful?

Uliana, D. L., Gomes, F. V., & Grace, A. A. (2023) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000854 · Cited by 15 · see citing works

Neurogenesis and sensorimotor gating: bridging a microphenotype and an endophenotype.

Osumi, N., Guo, N., Matsumata, M., & Yoshizaki, K. (2015) · Current molecular medicine · doi:10.2174/1566524015666150303002834 · Cited by 15 · see citing works

Corticolimbic circuitry as a druggable target in schizophrenia spectrum disorders: a narrative review

Gee, A., Dazzan, P., Grace, A. A., & Modinos, G. (2025) · Translational Psychiatry · doi:10.1038/s41398-024-03221-2 · Cited by 12 · see citing works

Reduced cortical GABA and glutamate in high schizotypy

Kozhuharova, P., Diaconescu, A. O., & Allen, P. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05867-y · Cited by 12 · see citing works

Elevated glutamate, glutamine and GABA levels and reduced taurine level in a schizophrenia model using an in vitro proton nuclear magnetic resonance method.

Yang, J., Guo, H., Sun, D., Duan, J., Rao, X., Xu, F., Manyande, A., Tang, Y., Wang, J., & Wang, F. (2019) · PubMed Central · Cited by 12 · see citing works

Spirituality, religion, and psychotic disorders

Huguelet, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816766-3.00005-7 · Cited by 9 · see citing works

Aberrant Hippocampal Development in Early-onset Mental Disorders and Promising Interventions: Evidence from a Translational Study

Yang, J., Guo, H., Cai, A., Zheng, J., Liu, J., Xiao, Y., Ren, S., Sun, D., Duan, J., Zhao, T., et al. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01162-2 · Cited by 9 · see citing works

Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis

Livingston, N. R., Kiemes, A., Devenyi, G. A., Knight, S., Lukow, P. B., Jelen, L. A., Reilly, T. J., Dima, A., Nettis, M. A., Casetta, C., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01864-9 · Cited by 9 · see citing works

Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High Risk for Psychosis

Livingston, N. R., Micheli, A. D., McCutcheon, R. A., Butler, E., Hamdan, M., Grace, A. A., McGuire, P. K., Egerton, A., Fusar‐Poli, P., & Modinos, G. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae036 · Cited by 8 · see citing works

Effects of environmental enrichment on the activity of the amygdala in micrencephalic rats exposed to a novel open field

Matsuda, W., Ehara, A., Nakadate, K., Yoshimoto, K., & Ueda, S. (2017) · Congenital Anomalies · doi:10.1111/cga.12228 · Cited by 8 · see citing works

Animal Models of Relevance to the Schizophrenia Prodrome

Petty, A. E., Howes, O. D., & Eyles, D. W. (2021) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.12.001 · Cited by 8 · see citing works

Adult stress exposure blunts dopamine system hyperresponsivity in a neurodevelopmental rodent model of schizophrenia

Rincón‐Cortés, M., & Grace, A. A. (2022) · Schizophrenia · doi:10.1038/s41537-022-00235-x · Cited by 7 · see citing works

Prefrontal Cortex Dysfunction as a Precipitating Factor for Schizophrenia and Depression

Uliana, D. L., & Grace, A. A. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70409 · Cited by 7 · see citing works

The ventral/anterior hippocampus as a central hub for stress-related dopaminergic circuit dysfunction in psychiatric disorders

Grace, A., & Uliana, D. L. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03513-7 · Cited by 6 · see citing works

Abnormalities in behavior relevant to schizophrenia in embryonic day 17 MAM-exposed rodent models: A systematic review and meta-analysis

Miao, Q., Zhu, P., Wang, H., He, Q., & Huo, C. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173888 · Cited by 6 · see citing works

What Can We Learn from Animal Models to Study Schizophrenia?

Crunfli, F., Brandão‐Teles, C., Zuccoli, G. S., Filho, A. J. M. C., Vieira, G. M., Silva-Amaral, D., Crippa, J. A. S., Pedrazzi, J. F. C., Macêdo, D. S., Bel, E. A. D., et al. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-97182-3_2 · Cited by 6 · see citing works

Towards an Integrated View of Early Molecular Changes Underlying Vulnerability to Social Stress in Psychosis

Barron, H., Hafizi, S., & Mizrahi, R. (2017) · Modern trends in psychiatry · doi:10.1159/000470810 · Cited by 6 · see citing works

GABA Dysfunction in Schizophrenia: The GABAA Receptor as a Potential Therapeutic Target

Crotchett, B. L. M., Reighard, S. D., & Nasrallah, H. A. (2025) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2025.100130 · Cited by 7 · see citing works

Short-term, but not long-term, beneficial effects of concomitant benzodiazepine use on clinical course in patients with schizophrenia

Ekinci, O., & Ekinci, A. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000392 · Cited by 5 · see citing works

Prenatal MAM treatment altered fear conditioning following social isolation: Relevance to schizophrenia

Bilecki, W., Latusz, J., Gawlińska, K., Chmelová, M., & Maćkowiak, M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113231 · Cited by 5 · see citing works

The methylazoxymethanol acetate rat model: molecular and epigenetic effect in the developing prefrontal cortex

Zhu, X., Gomes, F. V., & Grace, A. A. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14133 · Cited by 5 · see citing works

The antipsychotic agent sulpiride microinjected into the ventral pallidum restores positive symptom-like habituation disturbance in MAM-E17 schizophrenia model rats

Péczely, L., Dusa, D., Lénárd, L., Ollmann, T., Kertes, E., Gálosi, R., Berta, B., Szabó, Á., László, K., Zagorácz, O., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-63059-y · Cited by 4 · see citing works

Sex-dependent emergence of prepubertal social dysfunction and augmented dopamine activity in a neurodevelopmental rodent model relevant for schizophrenia

Rincón‐Cortés, M., & Grace, A. A. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.10.036 · Cited by 4 · see citing works

Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosis

Livingston, N. R., Kiemes, A., O’Daly, O., Knight, S., Lukow, P. B., Jelen, L. A., Reilly, T. J., Dima, A., Nettis, M. A., Casetta, C., et al. (2025) · Psychological Medicine · doi:10.1017/s0033291725101268 · Cited by 3 · see citing works

Neurochemical models of psychosis risk and onset

Oliver, D., Modinos, G., & McGuire, P. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813201-2.00012-0 · Cited by 3 · see citing works

Use of prepubertal environment enrichment to prevent dopamine dysregulation in a neurodevelopmental rat model of schizophrenia risk

Zhu, X., & Grace, A. A. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101215 · Cited by 3 · see citing works

Dysregulation of Dopamine Systems in a Developmental Disruption Model of Schizophrenia

Dibble, S. M., Du, Y., & Grace, A. A. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00008-0 · Cited by 3 · see citing works

Congenital blindness does not protect against a schizophrenia-related phenotype in rodents

Perez, S. M., Elam, H. B., McCoy, A. M., Boley, A. M., Eassa, N. E., & Lodge, D. J. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.06.007 · Cited by 2 · see citing works

Insights from Proteomic Studies on Schizophrenia Preclinical Models: What Can We Learn for Drug Discovery?

Farrelly, L. A., Föcking, M., & Cotter, D. (2014) · Advances in biological psychiatry · doi:10.1159/000358028 · Cited by 2 · see citing works

Parvalbumin and anxiety across development in female offspring of the MAM neurodevelopmental model of schizophrenia

Gurgel, S. E., Kumaran, C., Uliana, D. L., & Grace, A. A. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.07.002 · Cited by 1 · see citing works

The MAM Model to Study the Role of Dopamine in Schizophrenia

Zhu, X., Uliana, D. L., & Grace, A. A. (2022) · Neuromethods · doi:10.1007/978-1-0716-2799-0_10 · Cited by 1 · see citing works

Early risk factors in early-onset psychosis

Karlsgodt, K. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89832-4.00003-2 · Cited by 1 · see citing works

The MAM-E17 neurodevelopmental model of schizophrenia

Maćkowiak, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817988-8.00050-6 · Cited by 1 · see citing works

Tratamento repetido com canabidiol atenua alterações comportamentais e moleculares em um modelo de esquizofrenia baseado no antagonismo dos receptores NMDA

Gomes, F. V. (2016) · doi:10.11606/t.17.2016.tde-05012016-224242

Can Psychosis Be Prevented by Treating Adolescent Anxiety

Geller, B. (2013) · Journal watch · doi:10.1056/nejm-jw.na31194

GABA A and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophreniaPreprint

Kiemes, A., Gomes, F. V., Cash, D., Uliana, D. L., Simmons, C., Singh, N., Vernon, A. C., Turkheimer, F., Davies, C., Stone, J. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.21.449343

Efeitos do levetiracetam sobre as alterações comportamentais e eletrofisiológicas tipo-esquizofrenia induzidas pela exposição ao estresse na adolescência

Cavichioli, A. M. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-06052022-144555

Intrinsic metabolic and immune impairments in a genetic mouse model of schizophrenia

Belmonte, M., Cardoso, S. L., Pietro, A. A. D., Veigas, F., Pasquini, L. A., & Gelman, D. M. (2025) · Schizophrenia · doi:10.1038/s41537-025-00651-9

Dopamine dysfunction in psychosis

McCutcheon, R. A., & Zauchenberger, C.-Z. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-29867-7.00035-9

Abberant anxiety in schizophrenia: A potential target for early intervention

Du, Y. (2015)

Aberrant anxiety in schizophrenia: a potential target for early intervention

Du, Y. (2016) · D-Scholarship@Pitt (University of Pittsburgh)

Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration

Du, Y., & Grace, A. A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.42 · Cited by 59 · see citing works

S24. JUVENILITY AND ADOLESCENCE ARE CRITICAL PERIODS OF VULNERABILITY TO PSYCHOTOGENIC EFFECT OF STRESS: RELEVANCE TO SCHIZOPHRENIA

Zhu, X., Gomes, F. V., & Grace, A. A. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz020.569

The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention

Grace, A. A., & Gomes, F. V. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx199 · Cited by 152 · see citing works